Altered reactivity and nitric oxide signaling in the isolated thoracic duct from an ovine model of congenital heart disease with increased pulmonary blood flow

Autor: Sanjeev A. Datar, Michael J. Johengen, Jun Maki, Peter Oishi, Christine E. Sun, Stephen H. Bennett, Wenhui Gong, Jeffrey R. Fineman, Rebecca C. Johnson, Gary W. Raff
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Pulmonary Circulation
Time Factors
Physiology
Vascular Biology and Microcirculation
Muscle Relaxation
Medical Physiology
Cardiovascular
Congenital
chemistry.chemical_compound
Norepinephrine
2.1 Biological and endogenous factors
Aetiology
Lung
Cyclic GMP
Heart Defects
Pediatric
nitric oxide-cGMP signaling
Muscle relaxation
Lymphatic system
medicine.anatomical_structure
Inhalation
Anesthesia
Administration
Cardiology
Lymph
Drug
medicine.symptom
Endothelium
Lymphatic

Lymphatic
Cardiology and Cardiovascular Medicine
Blood Flow Velocity
Muscle Contraction
Signal Transduction
Heart Defects
Congenital

medicine.medical_specialty
Pulmonary Artery
S-Nitroso-N-Acetylpenicillamine
Nitric Oxide
Thoracic duct
Nitric oxide
Thoracic Duct
Dose-Response Relationship
Physiology (medical)
medicine.artery
Internal medicine
Administration
Inhalation

medicine
Animals
Nitric Oxide Donors
Endothelium
Sheep
Dose-Response Relationship
Drug

Animal
business.industry
Perinatal Period - Conditions Originating in Perinatal Period
Disease Models
Animal

Cardiovascular System & Hematology
chemistry
lymphatic endothelial function
Dilator
Disease Models
Pulmonary artery
business
Vasoconstriction
Zdroj: American journal of physiology. Heart and circulatory physiology, vol 306, iss 7
Datar, SA; Oishi, PE; Gong, W; Bennett, SH; Sun, CE; Johengen, M; et al.(2014). Altered reactivity and nitric oxide signaling in the isolated thoracic duct from an ovine model of congenital heart disease with increased pulmonary blood flow. American Journal of Physiology-Heart and Circulatory Physiology, 306(7), H954-H962. doi: 10.1152/ajpheart.00841.2013. UCSF: Retrieved from: http://www.escholarship.org/uc/item/0pk8x82r
Popis: We have previously shown decreased pulmonary lymph flow in our lamb model of chronically increased pulmonary blood flow, created by the in utero placement of an 8-mm aortopulmonary shunt. The purpose of this study was to test the hypothesis that abnormal lymphatic function in shunt lambs is due to impaired lymphatic endothelial nitric oxide (NO)-cGMP signaling resulting in increased lymphatic vascular constriction and/or impaired relaxation. Thoracic duct rings were isolated from 4-wk-old shunt ( n = 7) and normal ( n = 7) lambs to determine length-tension properties, vascular reactivity, and endothelial NO synthase protein. At baseline, shunt thoracic duct rings had 2.6-fold higher peak to peak tension and a 2-fold increase in the strength of contractions compared with normal rings ( P < 0.05). In response to norepinephrine, shunt thoracic duct rings had a 2.4-fold increase in vascular tone compared with normal rings ( P < 0.05) and impaired relaxation in response to the endothelium-dependent dilator acetylcholine (63% vs. 13%, P < 0.05). In vivo, inhaled NO (40 ppm) increased pulmonary lymph flow (normalized for resistance) ∼1.5-fold in both normal and shunt lambs ( P < 0.05). Inhaled NO exposure increased bioavailable NO [nitrite/nitrate (NO x); ∼2.5-fold in normal lambs and ∼3.4-fold in shunt lambs] and cGMP (∼2.5-fold in both) in the pulmonary lymph effluent ( P < 0.05). Chronic exposure to increased pulmonary blood flow is associated with pulmonary lymphatic endothelial injury that disrupts NO-cGMP signaling, leading to increased resting vasoconstriction, increased maximal strength of contraction, and impaired endothelium-dependent relaxation. Inhaled NO increases pulmonary lymph NO x and cGMP levels and pulmonary lymph flow in normal and shunt lambs. Therapies that augment NO-cGMP signaling within the lymphatic system may provide benefits, warranting further study.
Databáze: OpenAIRE